Zurcher Kantonalbank (Zurich Cantonalbank) Arbutus Biopharma Corp Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $33.8 Billion
- Q1 2025
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 84,163 shares of ABUS stock, worth $282,787. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84,163
Previous 89,665
6.14%
Holding current value
$282,787
Previous $293,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ABUS
# of Institutions
191Shares Held
111MCall Options Held
866KPut Options Held
608K-
Morgan Stanley New York, NY23.8MShares$79.9 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.3MShares$44.7 Million27.3% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$38.8 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY9.47MShares$31.8 Million1.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.95MShares$30.1 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $504M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...